Ceftriaxone !
A third-generation cephalosporin given by injection that reaches the brain and lasts all day; a mainstay for gonorrhoea, meningitis and pyelonephritis.
Updated 2026-11-01
The figure shows the transpeptidase domain of PBP2 from Neisseria gonorrhoeae acylated by ceftriaxone: the opened drug is bonded to the active-site serine.
Mechanism of action
Ceftriaxone acylates the PBPs and blocks peptidoglycan cross-linking, like the other β-lactams. It keeps activity in the presence of some β-lactamases (penicillinases and cephalosporinases), which gives it strong activity against gram-negatives such as gonococcus, meningococcus, H. influenzae and E. coli, and against pneumococcus and other streptococci.
- Resists many β-lactamases and reaches the PBPs intact
- Acylates PBP2 and other PBPs
- Cell-wall cross-linking stops
- The bacterium lyses; one daily dose keeps working
Pharmacokinetics
- Absorption
- Not absorbed by mouth; given IV or IM.
- Distribution
- Wide; penetrates inflamed meninges; largely and reversibly bound to plasma proteins.
- Elimination
- Two routes: a third to two-thirds unchanged in the urine, the rest in bile; for this reason kidney impairment alone usually needs no change, except when severe.
- Half-life
- About 6 to 9 hours in healthy adults, long for a β-lactam, which allows once-daily use.
Indications
- Uncomplicated gonorrhoea: the recommended treatment, with surveillance for resistance. Gonorrhoea →
- Bacterial meningitis caused by H. influenzae, meningococcus or pneumococcus. Bacterial meningitis →
- Lower respiratory tract infections, including community-acquired pneumonia in hospital. Community-acquired pneumonia →
- Complicated urinary tract infections such as acute pyelonephritis. Acute pyelonephritis →
- Prevention in close contacts of meningococcal disease and before some surgeries.
Adverse effects
Common
- Pain at the injection site
- Diarrhoea
- Rash
- Raised liver enzymes and eosinophilia
Contraindications
- Anaphylaxis to ceftriaxone or other β-lactams
- Premature newborns and newborns with hyperbilirubinaemia
- Newborns (28 days or younger) who need IV calcium-containing solutions
Key interactions
- IV calcium-containing solutions
- Ceftriaxone–calcium precipitates; never given at the same time, and avoided altogether in newborns who need calcium.
- Vitamin K antagonists (warfarin)
- Higher bleeding risk; prothrombin time can change.
What is monitored
- Right-upper-quadrant pain on long courses (biliary sludge)
- Blood count and liver tests on long courses
- Bilirubin in newborns
Test yourself
Think of the answer, then tap the question to see it.
A child on a long course of ceftriaxone develops right-upper-quadrant pain and ultrasound shows gallbladder sludge. What is the mechanism?
Ceftriaxone is partly excreted in bile, where it forms a calcium salt that precipitates (pseudolithiasis). It is transient and reverses after the drug is stopped.
Why is ceftriaxone avoided in jaundiced newborns?
It displaces bilirubin from albumin, raising free bilirubin and the risk of kernicterus.
Why can ceftriaxone usually be used without adjustment when only the kidneys are impaired?
It is cleared by two routes, urine and bile, so biliary excretion compensates; only severe kidney impairment calls for caution.
Why must ceftriaxone not be given at the same time as IV calcium-containing solutions?
The two form ceftriaxone–calcium precipitates; in newborns these have lodged in the lungs and kidneys, so the combination is contraindicated.
Related drugs
Related conditions
← Back to the class: Beta-lactams
Educational content on how drugs work; not a prescribing guide and no substitute for a health professional's advice. No doses are given.
Sources: Ceftriaxone Injection: MedlinePlus Drug Information (MedlinePlus (U.S. National Library of Medicine), 2026); DailyMed - CEFTRIAXONE injection, powder, for solution (DailyMed (U.S. National Library of Medicine), 2026); DailyMed - CEFTRIAXONE- ceftriaxone sodium injection, powder, for solution (DailyMed (U.S. National Library of Medicine), 2026); Gonococcal Infections Among Adolescents and Adults - STI Treatment Guidelines (Centers for Disease Control and Prevention (CDC), 2021).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.